Vera Therapeutics Inc (VERA)

NASDAQ
Currency in USD
22.22
-0.52(-2.29%)
Real-time Data·
VERA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VERA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.2223.14
52 wk Range
18.5351.61
Key Statistics
Edit
Prev. Close
22.74
Open
22.61
Day's Range
22.22-23.14
52 wk Range
18.53-51.61
Volume
824.72K
Average Volume (3m)
1.65M
1-Year Change
-36.87%
Book Value / Share
8.39
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VERA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
64.00
Upside
+188.03%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Vera Therapeutics Inc News & Analysis

Show more

Vera Therapeutics Company Profile

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company’s lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Compare VERA to Peers and Sector

Metrics to compare
VERA
Peers
Sector
Relationship
P/E Ratio
−8.2x−4.4x−0.5x
PEG Ratio
0.180.010.00
Price/Book
2.7x2.1x2.6x
Price / LTM Sales
-10.8x3.1x
Upside (Analyst Target)
177.0%178.1%51.1%
Fair Value Upside
Unlock2.4%8.9%Unlock

Analyst Ratings

13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 64.00
(+188.03% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
-0.81 / -0.7344
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

VERA Income Statement

FAQ

What Is the Vera Therapeutics (VERA) Stock Price Today?

The Vera Therapeutics stock price today is 22.22.

What Stock Exchange Does Vera Therapeutics Trade On?

Vera Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Vera Therapeutics?

The stock symbol for Vera Therapeutics is "VERA."

What Is the Vera Therapeutics Market Cap?

As of today, Vera Therapeutics market cap is 1.44B.

What Is Vera Therapeutics's Earnings Per Share (TTM)?

The Vera Therapeutics EPS (TTM) is -3.00.

When Is the Next Vera Therapeutics Earnings Date?

Vera Therapeutics will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is VERA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Vera Therapeutics Stock Split?

Vera Therapeutics has split 0 times.

How Many Employees Does Vera Therapeutics Have?

Vera Therapeutics has 152 employees.

What is the current trading status of Vera Therapeutics (VERA)?

As of 16 Jun 2025, Vera Therapeutics (VERA) is trading at a price of 22.22, with a previous close of 22.74. The stock has fluctuated within a day range of 22.22 to 23.14, while its 52-week range spans from 18.53 to 51.61.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.